Table 3.
Description and virucidal activity of eight commercial disinfectants tested against African swine fever virus and modified vaccinia virus Ankara.
| Disinfectant | Active Substance | Concentration of Disinfectant (%) | Active Substance Concentration (s) within the Concentration of Disinfectant Use (g/L) | Log10 Reduction | |
|---|---|---|---|---|---|
| ASFV | MVA | ||||
| 1 | PPMS + NaDCC | 0.40 | 2.00 + 0.20 | 4.67 | 4.00 |
| 2 | PPMS + MA | 0.50 | 2.50 + 0.50 | 6.17 | 4.00 |
| 3 | PPMS + NaDCC | 0.50 | 2.50 + 0.25 | 4.67 | 4.20 |
| 4 | GLT + QAC (BZK+DDAC) | 0.17 | 0.18 + 0.41 (BZK 0.28 + DDAC 0.13) | 4.17 | 2.67 |
| 0.20 | 0.21 + 0.50 (BZK 0.34 + DDAC 0.16) | n.d. | ≥3.30 * | ||
| 5 | GLT + QAC (BZK+DDAC) | 0.33 | 0.18 + 0.41 (BZK 0.28 + DDAC 0.13) | 4.17 | 3.17 |
| 0.40 | 0.21 + 0.50 (BZK 0.34 + DDAC 0.16) | n.d. | ≥3.00 * | ||
| 6 | CA + QAC (BZK) | 0.17 | 0.50 + 0.17 | 5.17 | 1.20 |
| 0.33 | 1.00 + 0.33 | n.d. | 1.83 | ||
| 0.50 | 1.50 + 0.50 | n.d. | 3.67 | ||
| 1.00 | 3.00 + 1.00 | n.d. | 4.00 | ||
| 1.33 | 4.00 + 1.33 | n.d. | 4.17 | ||
| 7 | CA + QAC (DDAC) | 0.17 | 0.33 + 0.17 | 5.17 | 1.80 |
| 2.00 | 4.00 + 2.00 | n.d. | ≥2.20 * | ||
| 8 | CA + SLS | 0.26 | 1.05 + 1.58 | 5.00 | 3.70 |
| 0.33 | 1.33 + 2.00 | n.d. | 3.80 | ||
| 0.50 | 2.00 + 3.00 | n.d. | 4.00 | ||
| 1.00 | 4.00 + 6.00 | n.d. | 4.70 | ||
PPMS, potassium peroxymonosulfate; NaDCC, sodium dichloroisocyanurate; GLT, glutaraldehyde; CA, citric acid; MA, malic acid; BZK, benzalkonium chloride; QAC, quaternary ammonium chloride; DDAC, didecyldimethylammonium chloride; SLS, sodium lauryl sulfate. ASFV, African swine fever virus; MVA, modified vaccinia virus Ankara; n.d., not done. Bold type, authorized use concentration against African swine fever virus. * Limitation encountered during determination owing to cytotoxicity.